S100A14 and neoplasm: When HIFU is combined with anti-PD-1, tumor proliferation-related genes such as Wnt7b,S100a14 and Erbb2 are significantly downregulated, and newly released tumor-specific antigens, cytokines, and cell fragments act as agonists of innate immunity (84).